It was a busy week for the public relations staff at Novartis, the Swiss based pharmaceutical giant. Their Canadian subsidiary, Sandoz Canada, entered into a partnership with Tilray to develop cannabinoid medicines. And their Washington, DC lobbyists were exposed —by Stormy Daniels’ lawyer!— for having paid a $1.2 million fee to Michael Cohen, Donald Trump’s “fixer,” as a consultant on healthcare policy. Aren’t you glad they made cannabis safe for capitalism?  —O’S News Service